Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton, 100 West 5th Street, Suite C124, Hamilton, ON, L8N 3K7, Canada.
Mood Disorders Program, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
BMC Womens Health. 2022 Mar 30;22(1):96. doi: 10.1186/s12905-022-01678-1.
Despite high co-morbidity between premenstrual dysphoric disorder and mood disorders, there is a gap of research-based tools to monitor concurrent premenstrual and mood symptoms. In this study, we developed a new DSM-5-based questionnaire to prospectively monitor concurrent premenstrual and mood symptoms.
Fifty-two females with bipolar or major depressive disorder, ages 16-45, were enrolled in the study. Participants completed two months of prospective symptom charting including the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS) and the Daily Record of Severity of Problems (DRSP). At the end of the prospective charting, participants also completed the Montgomery-Åsberg Depression Rating Scale (MADRS), Hamilton Depression Rating Scale (HDRS) and the Young Mania Rating Scale (YMRS). The MAC-PMSS was correlated with the DRSP, MADRS, HDRS and YMRS.
All individual items of the MAC-PMSS correlated strongly with the individual DRSP scores (all p < 0.001). The mood section of the MAC-PMSS also significantly correlated with MADRS (r = 0.572; p < 0.01), HDRS (r = 0.555; p < 0.01) and YMRS scores (r = 0.456; p < 0.01).
The MAC-PMSS is a reliable to tool to measure concurrent mood and premenstrual symptoms in women with mood disorders.
尽管经前烦躁障碍和情绪障碍之间存在高度共病，但仍缺乏基于研究的工具来监测同时出现的经前和情绪症状。在这项研究中，我们开发了一种新的基于 DSM-5 的问卷，以前瞻性监测同时出现的经前和情绪症状。
52 名年龄在 16-45 岁之间的双相或重性抑郁障碍女性参与了这项研究。参与者完成了两个月的前瞻性症状图表记录，包括麦克马斯特经前和情绪症状量表（MAC-PMSS）和每日严重程度记录（DRSP）。在前瞻性图表记录结束时，参与者还完成了蒙哥马利-阿斯伯格抑郁评定量表（MADRS）、汉密尔顿抑郁评定量表（HDRS）和杨氏躁狂评定量表（YMRS）。MAC-PMSS 与 DRSP、MADRS、HDRS 和 YMRS 相关。
MAC-PMSS 的所有单项均与 DRSP 个体得分高度相关（均 p<0.001）。MAC-PMSS 的情绪部分也与 MADRS（r=0.572；p<0.01）、HDRS（r=0.555；p<0.01）和 YMRS 得分（r=0.456；p<0.01）显著相关。
MAC-PMSS 是一种可靠的工具，可用于测量患有情绪障碍的女性同时出现的情绪和经前症状。
